Feb 5, 2026
how robust is ribociclib's safety and tolerability data compared to palbociclib and abemaciclib
and tolerability profile is well characterized across randomized trials, meta-analyses and , and shows a distinct pattern—predominantly hematologic and hepatic risks with a known signal for QTc prolon...